Vita Life Sciences Limited (VLS) Price & Analysis

Compare

13 Followers

VLS Stock Chart & Stats

AU$2.52

AU$0.00(0.00%)

At close: Jan 09 4:00 PM EST

AU$2.52

AU$0.00(0.00%)

Day’s Range― - ―

52-Week RangeAU$1.70 - AU$2.84

Previous CloseN/A

Volume18.65K

Average Volume (3M)14.76K

Market Cap

AU$142.01M

Enterprise ValueAU$109.06M

Total Cash (Recent Filing)AU$35.56M

Total Debt (Recent Filing)AU$4.30M

Price to Earnings (P/E)14.0

Beta-0.14

Next Earnings

Aug 20, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield4.33%

Share Statistics

EPS (TTM)0.10

Shares Outstanding54,620,354

10 Day Avg. Volume12,408

30 Day Avg. Volume14,758

Financial Highlights & Ratios

PEG Ratio0.74

Price to Book (P/B)2.57

Price to Sales (P/S)1.55

P/FCF Ratio9.11

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthSustained revenue expansion over multiple years shows durable end-market demand and successful distribution execution. A doubling of sales since 2020 indicates scalable product-market fit and provides a base for continued investment in channels and R&D, supporting medium-term growth prospects.

High Gross MarginsConsistently high gross margins indicate persistent product-level pricing power and favorable cost structure in core supplements. This margin profile supports durable operating profit generation, enabling reinvestment and dividend capacity even if SG&A rises moderately as the company scales.

Conservative Balance SheetLow leverage and a meaningful equity build provide financial flexibility for organic growth, M&A, or cyclical shocks. Strong recent ROE shows effective capital deployment historically, reducing solvency risk and supporting sustainable shareholder distributions and strategic investments over the coming months.

Bears Say

Margin CompressionA multi-year decline in net margin suggests rising cost pressures or less favourable mix as the business scales. If structural, persistent margin erosion would reduce free cash flow and limit reinvestment or payout capacity unless offset by pricing, efficiency gains, or higher-margin product development.

Cash Flow VolatilityInconsistent cash conversion points to working-capital swings or timing differences that make free cash flow less predictable. This variability can complicate capital allocation, dividend planning and stress testing for expansion, increasing operational risk despite healthy headline profitability.

Declining Returns On CapitalA downward trend in returns suggests incremental investments are yielding lower returns than earlier cycles. Over time this can constrain value creation, requiring either higher growth, improved margins, or more disciplined capital allocation to sustain shareholder returns at prior levels.

Vita Life Sciences Limited News

Vita Life Sciences Reports Ongoing Daily On-Market Share Buy-Back Activity

The latest update is out from Vita Life Sciences Limited ( ($AU:VLS) ). Vita Life Sciences Limited has...

7d ago

VLS

Vita Life Sciences Cancels 18,584 Shares Under On‑Market Buy-Back

Vita Life Sciences Limited ( ($AU:VLS) ) has provided an update. Vita Life Sciences Limited has cancelled 18,584...

3M ago

VLS

Vita Life Sciences Projects Strong FY2025 Growth Amid Market Expansion

Vita Life Sciences Limited ( ($AU:VLS) ) has issued an update. Vita Life Sciences has issued its FY2025...

3M ago

VLS

Vita Life Sciences Updates on Share Buy-Back Program

Vita Life Sciences Limited ( ($AU:VLS) ) just unveiled an update. Vita Life Sciences Limited has announced an...

3M ago

VLS

Vita Life Sciences Announces Cessation of Securities Through Buy-Back

Vita Life Sciences Limited ( ($AU:VLS) ) has provided an announcement. Vita Life Sciences Limited announced the cessation...

3M ago

VLS

Vita Life Sciences Announces Cessation of Securities

Vita Life Sciences Limited ( ($AU:VLS) ) has provided an update. Vita Life Sciences Limited announced the cessation...

3M ago

VLS

Vita Life Sciences Updates on Share Buy-Back Progress

An announcement from Vita Life Sciences Limited ( ($AU:VLS) ) is now available. Vita Life Sciences Limited has...

4M ago

VLS

Vita Life Sciences Updates on Securities Buy-Back Program

Vita Life Sciences Limited ( ($AU:VLS) ) has issued an update. Vita Life Sciences Limited has announced an...

4M ago

VLS

Vita Life Sciences Updates on Securities Buy-Back

Vita Life Sciences Limited ( ($AU:VLS) ) has provided an update. Vita Life Sciences Limited has announced a...

4M ago

VLS

Vita Life Sciences Announces Cessation of Securities via Buy-Back

Vita Life Sciences Limited ( ($AU:VLS) ) has issued an update. Vita Life Sciences Limited announced the cessation...

4M ago

VLS

VLS FAQ

What was Vita Life Sciences Limited’s price range in the past 12 months?

Vita Life Sciences Limited lowest share price was AU$1.70 and its highest was AU$2.84 in the past 12 months.

What is Vita Life Sciences Limited’s market cap?

Vita Life Sciences Limited’s market cap is AU$142.01M.

When is Vita Life Sciences Limited’s upcoming earnings report date?

Vita Life Sciences Limited’s upcoming earnings report date is Aug 20, 2026 which is in 169 days.

How were Vita Life Sciences Limited’s earnings last quarter?

Vita Life Sciences Limited released its earnings results on Feb 19, 2026. The company reported AU$0.1 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.1.

Is Vita Life Sciences Limited overvalued?

According to Wall Street analysts Vita Life Sciences Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Vita Life Sciences Limited pay dividends?

Vita Life Sciences Limited pays a Semiannually dividend of AU$0.045 which represents an annual dividend yield of 4.33%. See more information on Vita Life Sciences Limited dividends here

What is Vita Life Sciences Limited’s EPS estimate?

Vita Life Sciences Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Vita Life Sciences Limited have?

Vita Life Sciences Limited has 54,620,354 shares outstanding.

What happened to Vita Life Sciences Limited’s price movement after its last earnings report?

Vita Life Sciences Limited reported an EPS of AU$0.1 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.923%.

Which hedge fund is a major shareholder of Vita Life Sciences Limited?

Currently, no hedge funds are holding shares in AU:VLS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Vita Life Sciences Limited Stock Smart Score

Outperform

Fundamentals

Return on Equity

18.35%

Trailing 12-Months

Asset Growth

9.85%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Vita Life Sciences Limited

Vita Life Sciences Limited (VLS) is a health and wellness company that specializes in the development and distribution of nutritional supplements and dietary products. The company operates primarily in the consumer health sector, focusing on providing high-quality vitamins, minerals, and herbal supplements. VLS aims to enhance the well-being of its customers through its innovative product offerings, which cater to various health needs and promote a balanced lifestyle.